Carboplatin: the clinical spectrum to date

Area of Science:

• Oncology
• Pharmacology
• Clinical Chemistry

Background:

• Literature review of carboplatin efficacy and toxicity data up to June 1985.
• Carboplatin is a platinum-based chemotherapy drug.
• Comparison with cisplatin and iproplatin.

Purpose of the Study:

• To review existing literature on carboplatin.
• To assess carboplatin's efficacy and toxicity profile.
• To compare carboplatin with cisplatin and iproplatin.

Main Methods:

• Comprehensive literature search and review.
• Analysis of efficacy data for specific cancer types.
• Evaluation of toxicity data and therapeutic index.

Main Results:

• Carboplatin demonstrates a similar spectrum of activity to cisplatin.
• Efficacy data is established for ovarian, small cell lung, and head and neck cancers.
• Carboplatin exhibits an improved therapeutic index compared to cisplatin.
• Carboplatin's efficacy is comparable to iproplatin.

Conclusions:

• Carboplatin is an effective platinum-based chemotherapy agent.
• Carboplatin offers an improved safety profile over cisplatin.
• Carboplatin represents a viable alternative in platinum-based cancer therapy.